Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 28.09.2026 18 Alzheimers Dement 2 Am J Alzheimers Dis Other Demen 1 Ann Neurol 1 BMC Neurol 1 Br J Psychiatry 3 Curr Alzheimer Res 1 Exp Neurol 1 Geriatrics (Basel) 4 J Alzheimers Dis 1 J Am Geriatr Soc 1 J Biol Chem 1 J Neurochem 3 J Neurol 1 Lancet 1 Lancet Neurol 1 Nat Med 2 Nature 1 Neurochem Res 1 Neuropsychology 1 Neuroscience 1 PLoS One 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. MENG J, Wang Y, Wang J, Chen Y, et al
   TMEM59 regulates microglial Abeta phagocytosis in a TREM2-dependent manner and acts as a potential therapeutic target for Abeta amyloidosis.
   Alzheimers Dement. 2026;22:e71873.
   PubMed         Abstract available
   
   
2. PYUN JM, Park YH, Hwang J, Kim S, et al
   Transcriptional risk score for chronic kidney disease: relation to Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71798.
   PubMed         Abstract available
   
   
3. LI S, Lu J, Zeng K, Lu X, et al
   Aberrant phase separation from a rare ABI3 mutation drives microglial dysfunction and Alzheimer's risk.
   Alzheimers Dement. 2026;22:e71812.
   PubMed         Abstract available
   
   
4. ZHANG J, Liu D, Yang Y, Lou X, et al
   Mapping sex-specific associations of adiposity with age-related cognitive decline and multimodal Alzheimer's pathology.
   Alzheimers Dement. 2026;22:e71848.
   PubMed         Abstract available
   
   
5. KATTERI S, Wilks H, Welhaf M, Aschenbrenner AJ, et al
   Technology-natives and technology-adopters: Age differences in remote cognitive assessment in Alzheimer disease.
   Alzheimers Dement. 2026;22:e71872.
   PubMed         Abstract available
   
   
6. BHASKAR U, Kos MZ, Carless MA
   A cell-type-resolved meta-analysis reveals glial DNA methylation changes associated with aging and Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71864.
   PubMed         Abstract available
   
   
7. QIAO Q, Katsumata Y, Lai HY, Lin KZ, et al
   Distinct single-nucleus RNA-seq changes among non-neuronal cells in ADNC, LATE-NC, and mixed pathologies.
   Alzheimers Dement. 2026;22:e71810.
   PubMed         Abstract available
   
   
8. RITCHIE M, Hussen K, Langford O, Donohue MC, et al
   Research satisfaction among participants in a preclinical Alzheimer's disease trial.
   Alzheimers Dement. 2026;22:e71852.
   PubMed         Abstract available
   
   
9. MAN S, Gao Y, Mou K, Gao Y, et al
   Mendelian randomization evidence refines retinal alterations in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71879.
   PubMed        
   
   
10. WILLIAMS CA, Rose SE, Stamenkovic V, Reid AN, et al
    The Alzheimer's disease risk gene SORL1 is a regulator of excitatory neuronal function.
    Alzheimers Dement. 2026;22:e71862.
    PubMed         Abstract available
    
    
11. YE Z, Zhang Q, Zhang B, Teng B, et al
    Baseline cerebrospinal fluid complement balance is associated with longitudinal memory decline in relation to plasma p?tau181 levels in mild cognitive impairment.
    Alzheimers Dement. 2026;22:e71836.
    PubMed         Abstract available
    
    
12. 
    Correction to "Human iPSC-derived GABAergic interneuron transplantation restores circuit balance and cognitive function in an Alzheimer's disease model".
    Alzheimers Dement. 2026;22:e71875.
    PubMed        
    
    
13. PENG S, Butler-Laporte G, Johnson SC, Engelman CD, et al
    Genetic evidence suggests a protective role of immunoglobulin M in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71865.
    PubMed         Abstract available
    
    
14. LOPEZ-GONZALEZ FJ, Nemy M, Jerele C, Jimenez-Perez A, et al
    Post mortem MRI of cholinergic white matter pathways across neurodegenerative diseases.
    Alzheimers Dement. 2026;22:e71851.
    PubMed         Abstract available
    
    
15. GANTENBERG JR, La Joie R, Heston MB, Ackley SF, et al
    Do amyloid trajectories reach a ceiling? Evidence from iterative approximation and simulation.
    Alzheimers Dement. 2026;22:e71781.
    PubMed         Abstract available
    
    
16. SCODARI BT, Brown R, Jiang X, Shen C, et al
    Enhancing early Alzheimer's disease clinical trials through prognostic score covariate adjustment.
    Alzheimers Dement. 2026;22:e71849.
    PubMed         Abstract available
    
    
17. WANG Y, Chen Y, Kong H, Chen W, et al
    Unmasking preclinical Alzheimer's pathology: auditory distraction cost and occupational reserve jointly discriminate amyloid positivity in subjective cognitive decline.
    Alzheimers Dement. 2026;22:e71874.
    PubMed         Abstract available
    
    
18. CERVANTES GONZALEZ A, Morcillo-Nieto AO, Serrano S, Benejam B, et al
    Changes in serum beta-synuclein precede blood biomarkers of Alzheimer pathology in Down syndrome.
    Alzheimers Dement. 2026;22:e71860.
    PubMed         Abstract available
    
    

    
    Am J Alzheimers Dis Other Demen

19. ANDERSON JG, Dowling NM, Flatt JD
    Caregiving in Alzheimer's Disease and Related Dementias: Insights from Diverse Family Structures.
    Am J Alzheimers Dis Other Demen. 2026;41:15333175261489377.
    PubMed         Abstract available
    
    
20. TUMBAJOY-ARANGO CV, Trujillo N, Sanchez JP, Diaz DC, et al
    Social Determinants and Brain Health in PSEN1 E280A Carriers vs Non-Carriers: A Colombian Cohort.
    Am J Alzheimers Dis Other Demen. 2026;41:15333175261492405.
    PubMed         Abstract available
    
    

    
    Ann Neurol

21. LEONENKO G, Mavromati K, Hughes L, Sundarakumar JS, et al
    Genetic Resilience and Resistance in Alzheimer's Disease Diagnosis and Pathology.
    Ann Neurol. 2026 Sep 22. doi: 10.1002/ana.78367.
    PubMed         Abstract available
    
    

    
    BMC Neurol

22. XU X, Li J, Pan H, Zhao B, et al
    Insulin resistance and the risk of dementia: a systematic review and meta-analysis of prospective cohort studies.
    BMC Neurol. 2026;26:594.
    PubMed         Abstract available
    
    

    
    Br J Psychiatry

23. KOYCHEV I, Rowe JB, Amin J, Arsland D, et al
    Interpreting Evolving Evidence in Alzheimer's Disease: Implications for Dementia Clincians - CORRIGENDUM.
    Br J Psychiatry. 2026 Sep 21:1. doi: 10.1192/bjp.2026.10807.
    PubMed        
    
    

    
    Curr Alzheimer Res

24. PLUTA R, Ulamek-Koziol M
    Vitamin C versus Alzheimer's Disease. Commentary on the Effect of Ascorbic Acid on the Transgenic Drosophila Expressing Human Abeta-42 in the Neurons.
    Curr Alzheimer Res. 2026 Sep 17. doi: 10.2174/0115672050513704260903053055.
    PubMed         Abstract available
    
    
25. CHI L, Xu F, Dai X, Li Z, et al
    Immunity and Inflammation in Alzheimer's Disease: A Narrative Review on Mechanisms and Therapeutic Prospects.
    Curr Alzheimer Res. 2026 Sep 17. doi: 10.2174/0115672050493089260903062914.
    PubMed         Abstract available
    
    
26. WENXIN S, Youmao Z, Wenhua H
    Basic Research on the Lymphatic System and Exploratory Research in LVA Surgery for Alzheimer's Disease.
    Curr Alzheimer Res. 2026 Sep 16. doi: 10.2174/0115672050503391260907045733.
    PubMed         Abstract available
    
    

    
    Exp Neurol

27. SHEHU K, Onimisi OB, Bunza HA, Umar SM, et al
    Prenatal origins of neurodegeneration: The role of maternal immune activation in Alzheimer's and Parkinson's pathobiology.
    Exp Neurol. 2026;407:116029.
    PubMed         Abstract available
    
    

    
    Geriatrics (Basel)

28. ALKAM T, Tarshizi E, Van Benschoten AH
    Nonlinear Association of Length of Stay with In-Hospital Mortality in Alzheimer's Disease Hospitalizations: Admission-Only vs. Inpatient-Course Prediction Using Explainable Machine Learning.
    Geriatrics (Basel). 2026;11:136.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

29. ZHU Q, Chen W, Han X
    A multi-omics Mendelian randomization study identifies putatively causal genes and pathways for Alzheimer's disease associated with reactive astrocytes.
    J Alzheimers Dis. 2026 Sep 23:13872877261489741. doi: 10.1177/13872877261489741.
    PubMed         Abstract available
    
    
30. UCHIYAMA M, Sato T, Mamiya Y, Takato T, et al
    Functional hearing difficulty in Alzheimer's disease: Selective links to verbal fluency and behavioral and psychological symptoms of dementia severity.
    J Alzheimers Dis. 2026 Sep 22:13872877261489803. doi: 10.1177/13872877261489803.
    PubMed         Abstract available
    
    
31. YANG Y, Kwak YT
    Neuropsychiatric symptom-role reorganization in amyloid PET-positive Alzheimer's disease: An expanded-cohort analysis.
    J Alzheimers Dis. 2026 Sep 23:13872877261489744. doi: 10.1177/13872877261489744.
    PubMed         Abstract available
    
    
32. ARAI H, Aiba S, Yamamoto H, Akiba Y, et al
    Clinic-based real-world analysis of amyloid PET positivity and MRI markers across subjective cognitive decline, mild cognitive impairment, and early Alzheimer's disease.
    J Alzheimers Dis. 2026 Sep 23:13872877261490596. doi: 10.1177/13872877261490596.
    PubMed         Abstract available
    
    

    
    J Am Geriatr Soc

33. KUO YF, Tzeng HM, Shan Y, Jang JH, et al
    Association Between Annual Wellness Visits and Early Dementia Diagnoses: Roles of Post-Visit Healthcare Decisions.
    J Am Geriatr Soc. 2026;74:2652-2658.
    PubMed         Abstract available
    
    

    
    J Biol Chem

34. STEINER H, Breimann S, Kamp F, Frishman D, et al
    From mechanism to substratome: Unraveling mysteries of gamma-secretase.
    J Biol Chem. 2026;302:113287.
    PubMed         Abstract available
    
    

    
    J Neurochem

35. 
    Correction to 'Exercise Snacking in Alzheimer's Disease: A Mechanistic Rationale Based on Repeated Exerkine Signaling'.
    J Neurochem. 2026;170:e70560.
    PubMed        
    
    

    
    J Neurol

36. MCCANN E, Coleman F, Lee S, Fazlollahi A, et al
    Dorsal and ventral stream visuoperceptual processing deficits in Lewy body disease.
    J Neurol. 2026;273:620.
    PubMed         Abstract available
    
    
37. FERNANDEZ A, Molanes-Lopez EM, Zuluaga P, Vaquero L, et al
    The link between plasma and cognitive markers for Alzheimer's disease in Down syndrome: a longitudinal study.
    J Neurol. 2026;273:619.
    PubMed         Abstract available
    
    
38. OWEN AM
    What have trials targeting amyloid in Alzheimer's told us to date? The conversation the Alzheimer's field isn't having.
    J Neurol. 2026;273:617.
    PubMed         Abstract available
    
    

    
    Lancet

39. MAURE-BLESA L, Carmona-Iragui M, Barroeta I, Arranz J, et al
    Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study.
    Lancet. 2026 Sep 3:S0140-6736(26)00980-3. doi: 10.1016/S0140-6736(26)00980.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

40. MU R, Hofmann A, Gong K, Liu M, et al
    Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study.
    Lancet Neurol. 2026 Sep 24:S1474-4422(26)00284.
    PubMed         Abstract available
    
    

    
    Nat Med

41. HE C, Li AZ, Hanthanan Arachchilage K, Gupta C, et al
    AI-based characterization of Alzheimer's disease phenotypes from population-scale single-cell data.
    Nat Med. 2026 Sep 23. doi: 10.1038/s41591-025-04128.
    PubMed         Abstract available
    
    

    
    Nature

42. LEE D, Koutrouli M, Masse NY, Hoffman GE, et al
    Single-cell atlas of transcriptomic vulnerability across brain disorders.
    Nature. 2026;657:988-1002.
    PubMed         Abstract available
    
    
43. HEIDT A
    Landmark map of human brain's gene activity holds clues to Alzheimer's disease and more.
    Nature. 2026 Sep 23. doi: 10.1038/d41586-026-02947.
    PubMed        
    
    

    
    Neurochem Res

44. MAESHIBA M, Kajiya H, Migita K, Goto-T K, et al
    Restoration of Normal Occlusion Suppresses the Risk of Dementia.
    Neurochem Res. 2026;51:273.
    PubMed         Abstract available
    
    

    
    Neuropsychology

45. STITES SD, Schumann R, Shi Y, Mechanic-Hamilton D, et al
    Depression and anxiety modify cognitive concerns associated with amyloid and early clinical impairment.
    Neuropsychology. 2026;40:750-762.
    PubMed         Abstract available
    
    

    
    Neuroscience

46. LI T, Sheng J, Zhang Q, Gong Z, et al
    An enhanced grey wolf optimizer-based Facebook artificial intelligence similarity search for Alzheimer's disease diagnosis.
    Neuroscience. 2026 Sep 24:S0306-4522(26)00645.
    PubMed         Abstract available
    
    

    
    PLoS One

47. RANJAN R, Kawnayn G, Yusuf MA, Uddin MN, et al
    Age at dementia diagnosis, subtype associations, and neuroimaging differentiation in Bangladesh: The CARED study.
    PLoS One. 2026;21:e0359109.
    PubMed         Abstract available
    
    

    
    Science

48. 
    Erratum for the Research Article "Modeling of late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming".
    Science. 2026;393:eaem2402.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum